STOCK TITAN

Bank of Marin (BMRC) CEO lets several stock option grants expire

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Bank of Marin Bancorp president and CEO Timothy D. Myers reported the expiration of several stock option awards without exercise. These include 1,300 options with a $22.94 exercise price that expired on April 1, 2024, 2,980 options at $25.38 that expired on March 2, 2025, and 5,380 options at $24.83 that expired on March 1, 2026.

The filing notes these options were fully vested but lapsed unexercised and that this Form 4 is being filed late due to an administrative oversight. Myers continues to hold 124,173.3268 shares of common stock directly, 14,786.186 shares indirectly through an ESOP, and multiple remaining option grants, including 4,629 options at $34.03 expiring in 2032 and 3,616 options at $38.11 expiring in 2031.

Positive

  • None.

Negative

  • None.
Insider Myers Timothy D
Role PRESIDENT & CEO
Type Security Shares Price Value
H Stock Options (Right to Buy) 5,380 $0.00 --
H Stock Options (Right to Buy) 2,980 $0.00 --
H Stock Options (Right to Buy) 1,300 $0.00 --
holding Stock Options (Right to Buy) -- -- --
holding Stock Options (Right to Buy) -- -- --
holding Stock Options (Right to Buy) -- -- --
holding Stock Options (Right to Buy) -- -- --
holding Stock Options (Right to Buy) -- -- --
holding Stock Options (Right to Buy) -- -- --
holding Stock Options (Right to Buy) -- -- --
holding Stock Options (Right to Buy) -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Stock Options (Right to Buy) — 0 shares (Direct, null); Common Stock — 124,173.327 shares (Direct, null); Common Stock — 14,786.186 shares (Indirect, By ESOP)
Footnotes (1)
  1. The stock option was granted on April 1, 2014 and vested in equal annual installments over five years, becoming fully exercisable on April 1, 2019. The option expired unexercised on April 1, 2024. This Form 4 is being filed late due to an administrative oversight. Exercisable 20% per year beginning on first anniversary date of grant. The stock option was granted on March 2, 2015 and vested in equal annual installments over three years, becoming fully exercisable on March 2, 2018. The option expired unexercised on March 2, 2025. This Form 4 is being filed late due to an administrative oversight. Exercisable 33% per year beginning on first anniversary date of grant. The stock option was granted on March 1, 2016 and vested in equal annual installments over three years, becoming fully exercisable on March 1, 2019. The option expired unexercised on March 1, 2026. This Form 4 is being filed late due to an administrative oversight. Exercisable 33% per year beginning on first anniversary date of grant.
Expired options 2024 1,300 options at $22.94 Expired unexercised on April 1, 2024
Expired options 2025 2,980 options at $25.38 Expired unexercised on March 2, 2025
Expired options 2026 5,380 options at $24.83 Expired unexercised on March 1, 2026
Direct common stock holding 124,173.3268 shares Common stock held directly as of April 1, 2024
Indirect ESOP holding 14,786.186 shares Common stock held indirectly by ESOP as of April 1, 2024
Option block at $34.03 4,629 underlying shares Options expiring March 1, 2032, held directly
Option block at $38.11 3,616 underlying shares Options expiring October 29, 2031, held directly
Option block at $44.45 3,600 underlying shares Options expiring March 1, 2029, held directly
Stock Options (Right to Buy) financial
"security_title": "Stock Options (Right to Buy)""
derivative expiration/cancellation financial
"transaction_action": "derivative expiration/cancellation""
Employee Stock Ownership Plan financial
"nature_of_ownership": "By ESOP""
An employee stock ownership plan (ESOP) is a company-run program that gives workers ownership stakes by allocating or letting them buy company shares, often through a retirement-style account. For investors, ESOPs matter because they align employees’ incentives with company performance—like turning staff into shareholders—which can boost productivity and long-term value but may also concentrate employee retirement savings in company stock, affecting financial risk and share demand.
administrative oversight regulatory
"This Form 4 is being filed late due to an administrative oversight."
exercise price financial
"conversion_or_exercise_price": "34.0300""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Myers Timothy D

(Last)(First)(Middle)
504 REDWOOD BLVD., SUITE 100

(Street)
NOVATO CALIFORNIA 94947

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Bank of Marin Bancorp [ BMRC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
PRESIDENT & CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/01/2024
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock124,173.3268D
Common Stock14,786.186IBy ESOP
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options (Right to Buy)$22.9404/01/2024H(1)1,30004/01/2019(2)04/01/2024Common Stock1,300$00D
Stock Options (Right to Buy)$25.3803/02/2025H(3)2,98003/02/2018(4)03/02/2025Common Stock2,980$00D
Stock Options (Right to Buy)$24.8303/01/2026H(5)5,38003/01/2019(4)03/01/2026Common Stock5,380$00D
Stock Options (Right to Buy)$34.8 (4)03/01/2027Common Stock3,7203,720D
Stock Options (Right to Buy)$33.58 (6)03/01/2028Common Stock2,0002,000D
Stock Options (Right to Buy)$33.58 (4)03/01/2028Common Stock4,1404,140D
Stock Options (Right to Buy)$44.45 (4)03/01/2029Common Stock3,6003,600D
Stock Options (Right to Buy)$40.1 (4)03/02/2030Common Stock2,6702,670D
Stock Options (Right to Buy)$38.25 (4)03/01/2031Common Stock2,0992,099D
Stock Options (Right to Buy)$38.1110/29/202110/29/2031Common Stock3,6163,616D
Stock Options (Right to Buy)$34.03 (4)03/01/2032Common Stock4,6294,629D
Explanation of Responses:
1. The stock option was granted on April 1, 2014 and vested in equal annual installments over five years, becoming fully exercisable on April 1, 2019. The option expired unexercised on April 1, 2024. This Form 4 is being filed late due to an administrative oversight.
2. Exercisable 20% per year beginning on first anniversary date of grant.
3. The stock option was granted on March 2, 2015 and vested in equal annual installments over three years, becoming fully exercisable on March 2, 2018. The option expired unexercised on March 2, 2025. This Form 4 is being filed late due to an administrative oversight.
4. Exercisable 33% per year beginning on first anniversary date of grant.
5. The stock option was granted on March 1, 2016 and vested in equal annual installments over three years, becoming fully exercisable on March 1, 2019. The option expired unexercised on March 1, 2026. This Form 4 is being filed late due to an administrative oversight.
6. Exercisable 33% per year beginning on first anniversary date of grant.
/s/ Krissy Meyer, Attorney-in-Fact05/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider activity did Bank of Marin Bancorp (BMRC) report in this Form 4?

The Form 4 reports that CEO Timothy D. Myers had several vested stock option grants lapse unexercised. Specifically, options granted in 2014, 2015, and 2016 reached their expiration dates and were cancelled without being exercised, with no open-market share purchases or sales disclosed.

How many Bank of Marin Bancorp stock options expired for the CEO and at what prices?

Three option grants for CEO Timothy D. Myers expired unexercised: 1,300 options at $22.94, 2,980 options at $25.38, and 5,380 options at $24.83 per share. All were fully vested before expiration and represent a loss of potential, not an actual stock sale.

Does this BMRC Form 4 show any open-market buying or selling by the CEO?

The filing does not show any open-market purchases or sales. It records derivative expirations and current holdings, with transaction codes indicating option cancellations rather than buy or sell trades. The transaction summary shows no buy or sell share counts and a neutral net direction.

What Bank of Marin Bancorp shares does the CEO hold after these option expirations?

After the reported expirations, CEO Timothy D. Myers holds 124,173.3268 BMRC common shares directly and 14,786.186 shares indirectly through an ESOP. He also retains several option grants on common stock at exercise prices between $33.58 and $44.45 with expirations from 2027 to 2032.

Why does the BMRC Form 4 mention an administrative oversight?

Footnotes explain the Form 4 is filed late because of an administrative oversight. Options granted in 2014, 2015, and 2016 expired unexercised on their respective 2024–2026 expiration dates, and the company notes the delay in reporting these routine derivative expirations in the insider trading report.

What future stock option rights does the Bank of Marin CEO still have according to this filing?

The derivative summary lists multiple remaining option grants on BMRC common stock, such as 4,629 options at $34.03 expiring March 1, 2032 and 3,600 options at $44.45 expiring March 1, 2029. These options provide potential future share acquisitions if exercised before expiration.